Durvalumab Plus Oleclumab Combined With Chemotherapy and Bevacizumab for Metastatic Microsatellite-Stable Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer
Br. J. Cancer 2024 Jul 25;[EPub Ahead of Print], NH Segal, J Tie, S Kopetz, M Ducreux, E Chen, R Dienstmann, A Hollebecque, MJ Reilley, E Elez, J Cosaert, J Cain, Y Soo-Hoo, N Hewson, ZA Cooper, R Kumar, J TaberneroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.